Hiroaki Kobayashi

TXP Medical, Inc. specializes in providing patient information record and management systems for emergency hospitals. TXP Medical is based in Japan and was founded in 2017 by Tomohiro Sono. The Japanese company's products include Next Stage ER, a paperless system for efficient patient information records and information sharing among staff, Next Stage Oncology, a database system that improves the speed and quality of medical treatment and research, NSER Mobile, an emergency support app that digitizes emergency patient information and links information in the cloud, and an interview system that allows for collaboration and incorporation of electronic medical records. The company also offers a clinic and hospitalization support system for corona-infected patients and an acute clinical trial support service for pharmaceuticals and medical device manufacturers. The company has a rare research system that includes an academic research department gathering students and doctors from all over the country.

TXP Medical, Inc. specializes in providing patient information record and management systems for emergency hospitals. TXP Medical is based in Japan and was founded in 2017 by Tomohiro Sono. The Japanese company's products include Next Stage ER, a paperless system for efficient patient information records and information sharing among staff, Next Stage Oncology, a database system that improves the speed and quality of medical treatment and research, NSER Mobile, an emergency support app that digitizes emergency patient information and links information in the cloud, and an interview system that allows for collaboration and incorporation of electronic medical records. The company also offers a clinic and hospitalization support system for corona-infected patients and an acute clinical trial support service for pharmaceuticals and medical device manufacturers. The company has a rare research system that includes an academic research department gathering students and doctors from all over the country.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.

Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.

Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.

Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.

Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD.

University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan.